The focus of my research is to understand patterns of care, comparative effectiveness of treatments, and quality of care for patients with hematologic malignancies, throughout the continuum of disease from diagnosis through the end of life (EOL). I am currently conducting an analysis utilizing the linked SEER-Medicare database to characterize variations in EOL care for different groups of blood cancers. I am also developing a national physician survey to characterize hematologic oncologistsâ€™ perspectives and decision-making processes regarding EOL care for patients with blood cancers. The ultimate goal of this project is to develop targeted interventions to improve quality of EOL care for patients with hematologic cancers. I conduct my research in the Center for Outcomes and Policy Research at the Dana-Farber Cancer Institute, with mentorship from Dr. Gregory Abel.